Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Revision Rate Due to Infection With Single-dose Versus Multiple-dose Antibiotic Prophylaxis During Primary Hip- and Knee Arthroplasty: A Hybrid Effectiveness Implementation Target Trial Emulation Study.

NCT07053943 is registered in ClinicalTrials.gov with JointResearch as lead sponsor.

NCT NCT07053943
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07053943 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Revision Rate Due to Infection With Single-dose Versus Multiple-dose Antibiotic Prophylaxis During Primary Hip- and Knee Arthroplasty: A Hybrid Effectiveness Implementation Target Trial Emulation Study.
Lead sponsor
JointResearch
Phase
Observational
Overall status
Enrolling by invitation
Start date
June 1, 2025
Completion date
May 31, 2027
Enrollment
70,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic prophylaxis, revision arthroplasty, total hip arthroplasty (tha), total knee arthroplasty